Hyperemesis gravidarum is a condition characterized by persistent and excessive vomiting during pregnancy. It is diagnosed when a pregnant woman experiences weight loss of over 5% of her pre-pregnancy weight along with ketonuria unrelated to other causes. Symptoms typically begin around 5-6 weeks of gestation and peak at 9 weeks, usually resolving by 16-20 weeks. Laboratory tests may show dehydration, electrolyte imbalances, and elevated liver enzymes. The exact causes are unknown but are likely multifactorial involving genetic, hormonal, gastrointestinal, and psychological factors.
Hyperemesis gravidarum is a condition characterized by persistent and excessive vomiting during pregnancy. It is diagnosed when a pregnant woman experiences weight loss of over 5% of her pre-pregnancy weight along with ketonuria unrelated to other causes. Symptoms typically begin around 5-6 weeks of gestation and peak at 9 weeks, usually resolving by 16-20 weeks. Laboratory tests may show dehydration, electrolyte imbalances, and elevated liver enzymes. The exact causes are unknown but are likely multifactorial involving genetic, hormonal, gastrointestinal, and psychological factors.
Hyperemesis gravidarum is a condition characterized by persistent and excessive vomiting during pregnancy. It is diagnosed when a pregnant woman experiences weight loss of over 5% of her pre-pregnancy weight along with ketonuria unrelated to other causes. Symptoms typically begin around 5-6 weeks of gestation and peak at 9 weeks, usually resolving by 16-20 weeks. Laboratory tests may show dehydration, electrolyte imbalances, and elevated liver enzymes. The exact causes are unknown but are likely multifactorial involving genetic, hormonal, gastrointestinal, and psychological factors.
Hyperemesis gravidarum is a condition characterized by persistent and excessive vomiting during pregnancy. It is diagnosed when a pregnant woman experiences weight loss of over 5% of her pre-pregnancy weight along with ketonuria unrelated to other causes. Symptoms typically begin around 5-6 weeks of gestation and peak at 9 weeks, usually resolving by 16-20 weeks. Laboratory tests may show dehydration, electrolyte imbalances, and elevated liver enzymes. The exact causes are unknown but are likely multifactorial involving genetic, hormonal, gastrointestinal, and psychological factors.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 73
HYPEREMESIS GRAVIDARUM
By: Solomon Berhe
OBGYN resident Definition Common criteria for diagnosis of hyperemesis are persistent vomiting accompanied by weight loss exceeding 5 percent of prepregnancy body weight and ketonuria unrelated to other causes. Alternatively, the diagnosis can be made in women with pregnancy-related vomiting that occurs greater than three times per day with weight loss greater than 3 kg or 5 percent of body weight and ketonuria . Cont… The mean onset of symptoms is at 5 to 6 weeks of gestation, peaking at about 9 weeks, and usually abating by 16 to 20 weeks of gestation; however, symptoms may continue until the third trimester in 15 to 20 percent of gravida and until delivery in 5 percent. Sixty percent of women are asymptomatic six weeks after onset of nausea. If vomiting persists beyond a few days postpartum , other etiologies should be investigated. Cont… Maternal factors shown to increase the rate of hospitalization due to hyperemesis gravidarum include: Hyperthyroidism Psychiatric disorders Diabetes Gastrointestinal disorders and Asthma Cont… About 10% of patients are affected throughout pregnancy. This disorder leads to elective pregnancy termination in approximately 2% of affected pregnancies. Cont… In contrast to women with mild disease, women with hyperemesis have orthostatic hypotension, laboratory abnormalities, and physical signs of dehydration, and often require hospitalization for stabilization. In addition, many women with hyperemesis hypersalivate (ptyalism) INCIDENCE Some degree of nausea with or without vomiting occurs in 50 to 90 percent of all pregnancies. The incidence of women with severe symptoms is not well-documented; reports vary from 0.3 to 2 percent of pregnancies. Ethnic differences and differences in the definition of the disease may account, in part, for the variability. Cont… more common in Western nations and urban areas than in Africa and Asia. Younger primigravid women are more likely to be affected than older multiparous women, but data have not been consistent. Incidence Cont… – There has been marked fall in the incidence during the last 30yrs.the reasons are: Better application of family planning knowledge which reduces the number of unplanned pregnancies. Early visit to the antenatal clinic and Potent antihistaminic, antiemetic drugs. Risk factors Nonpregnant women who experience nausea and vomiting related to estrogen–based medication, motion, or migraine. Women who are supertasters are also at increased risk; in contrast, anosmic women appear to be at low risk women with multiple gestations, women with hydatidiform mole women who did not take multivitamins either prior to 6 weeks of gestation or during the peri-conceptional period and women with heartburn and acid reflux Cont… genetic factors appear to play a role. A population- based cohort study found that daughters of women with hyperemesis were at significantly higher risk of developing hyperemesis in their own pregnancy compared to daughters of women without hyperemesis (3 versus 1 percent), while female partners of sons of women with hyperemesis were not at increased risk . Other studies have reported a significantly higher risk of hyperemesis gravidarum in women whose sister or mother experienced the disorder, in monozygotic twins compared with dizygotic twins, and in women with certain genetically determined conditions. Cont…. Interestingly, studies consistently report a preponderance of female fetuses among pregnancies complicated by hyperemesis (odds of female fetus 1.27, 95% CI 1.21-1.34). Alcohol use and cigarette smoking (perhaps due to the effect of nicotine) appear to be protective factors Cont… Scoring systems — The Motherisk-PUQE scoring index and the Rhodes Index are tools for quantifying the severity of nausea and vomiting in pregnancy and following the course of the condition; they have been used predominantly in research studies . These indices use a point system to assign points for the number of hours each day the woman feels nauseated, the number of times she vomits, and the number of times she has dry heaves. A high score indicates the woman should be evaluated for dehydration and her serum electrolyte levels should be checked. Some clinicians find that these tools are helpful in assessing symptoms in their patients, but they have not been validated for guiding management of nausea and vomiting of pregnancy in the clinical setting. PATHOGENESIS The predominant theories are described below: Psychologic factors: (1) a conversion or somatization disorder or (2) a response to stress A feeling of ambivalence about the pregnancy has been proposed as an etiologic or contributing factor. The woman’s psychological response to persistent nausea and vomiting may exacerbate her symptoms as a result of conditioning. Cont… Hormonal changes : No single hormonal profile can accurately predict the presence of hyperemesis gravidarum. Elevated serum concentrations of estrogen and progesterone have long been implicated in the pathogenesis of this disorder. These hormones relax smooth muscle and thus slow gastrointestinal transit time and may alter gastric emptying. Cont… serum concentrations of human chorionic gonadotropin (hCG) peak during the first trimester, the time when hyperemesis gravidarum is typically seen. A causal association between hCG levels and hyperemesis gravidarum has not been firmly established. Cont… Abnormal gastrointestinal motility: Gastric motility may be abnormal (delayed or dysrhythmic) in women with hyperemesis gravidarum. Helicobacter pylori — Most women with H. pylori do not develop severe nausea and vomiting in pregnancy, but the infection may play a role in pathogenesis of disease in some women. Pathogenesis cont… Vomiting — Vomiting is a reflex that allows an animal to rid itself of ingested toxins or poisons. It can be activated by humoral or neuronal stimuli, or both. Multiple afferent and efferent pathways exist which induce vomiting; the following are the major components of these pathways: The area postrema in the floor of the fourth ventricle which contains a "chemoreceptor trigger zone" that is sensitive to many humoral factors, including neurotransmitters, peptides, drugs, and toxins. Cont… Vagal afferent nerves from the gastrointestinal tract synapse in the NTS. From there, some neurons extend to the area postrema; other neurons from the NTS ascend to the paraventricular nuclei of the hypothalamus and the limbic and cortical regions, where gastric electromechanical events are perceived as normal sensations or symptoms such as nausea or discomfort. Cont… An area in the medulla known as the nucleus tractus solitarius (NTS) which may serve as a central pattern generator for vomiting; information from humoral factors via the area postrema and visceral afferents via the vagus nerve may converge at this site. The central pattern generator presumably projects to the various motor nuclei to elicit the sequential excitation and inhibition that controls the vomiting reflex. Diagnosis Clinical symptoms include: Dry mouth Sialorrhea Hyperolfaction and Altered taste. Physical Examination: Tachycardia, hypotension Dry mucous membranes Poor skin turgor INVESTIGATION • The standard initial evaluation of pregnant women with persistent nausea and vomiting includes measurement of: Weight Orthostatic blood pressures Heart rate serum electrolytes, and urine ketones and specific gravity An obstetrical ultrasound examination is performed to look for gestational trophoblastic disease and multiple gestation, Cont… Based on patient-specific factors, such as severity of disease and associated symptoms, one or more of the following additional blood tests can be ordered to assess the woman’s volume/metabolic status or to exclude other diagnoses: Blood urea nitrogen, creatinine complete blood count liver function tests, thyroid function tests Amylase/lipase, and calcium level. lab Findings — Laboratory abnormalities that can be caused by nausea and vomiting of pregnancy include: Electrolyte and acid-base derangements, such as hypokalemia and hypochloremic metabolic alkalosis, from vomiting gastric secretions. Ketosis can occur if caloric intake is minimal. An increase in hematocrit, indicating hemoconcentration due to plasma volume depletion. The degree of hemoconcentration may be underestimated unless the physiologic decline in hematocrit seen in normal pregnancies is considered. Other signs of dehydration include an elevated blood urea nitrogen and urine specific gravity. Cont… Abnormal liver enzyme values occur in approximately 50 percent of patients who are hospitalized with hyperemesis. The most striking abnormality is an increase in serum aminotransferases. Alanine aminotransferase (ALT) is typically elevated to a greater degree than aspartate aminotransferase (AST). Values for both are typically only mildly elevated, eg, in the low hundreds or two to three times the upper limit of normal, and rarely as high as 1000 U/L. Hyperbilirubinemia also can occur, but rarely exceeds 4 mg/dL . Cont… The degree of abnormality in liver tests correlates with severity of vomiting; the highest elevations are seen in patients with the most severe or protracted vomiting. Abnormal liver biochemical tests resolve promptly upon resolution of vomiting. When a liver biopsy has been performed, it was either normal or showed nonspecific findings. Inflammation was absent, but necrosis with cell drop out, steatosis centrilobular vacuolization, and rare bile plugs have been seen . These changes help to explain the mechanism for the Cont… Serum amylase and lipase may increase as much as 5-fold (as opposed to a 5- to 10-fold increase in acute pancreatitis) and are of salivary rather than pancreatic origin Mild hyperthyroidism, possibly due to high serum concentrations of human chorionic gonadotropin which has thyroid-stimulating activity. One report noted low serum TSH concentrations more often in women with hyperemesis gravidarum than in normal Cont… Features that distinguish the transient hyperthyroidism of hyperemesis gravidarum from hyperthyroidism of other causes (which in a pregnant woman is most likely due to Graves' disease) are: the vomiting absence of goiter and ophthalmopathy, and absence of the common symptoms and signs of hyperthyroidism (heat intolerance, muscle weakness, tremor). In addition, serum free T4 concentrations are only minimally elevated and serum T3 concentrations are not elevated in women with hyperemesis gravidarum, whereas both are usually unequivocally elevated in pregnant women with true DIFFERENTIAL DIAGNOSIS Nausea and vomiting that develop after 10 weeks of gestation are not likely due to this disorder. The presence of associated signs and symptoms, such as bilious emesis, abdominal pain, fever, headache, abnormal neurologic findings, diarrhea, constipation, leukocytosis, goiter, or hypertension, also suggests another diagnosis is likely. Differential diagnosis Cont… UTI, (Pyelonephritis) Uncontrolled diabetes Hepatitis Pancreatitis MANAGEMENT GOAL OF TREATMENT — The treatment goals in patients with nausea and vomiting of pregnancy are to: Reduce symptoms through changes in diet/environment and by medication Correct consequences or complications of nausea and vomiting (eg, fluid depletion, hypokalemia, and metabolic alkalosis) Minimize the fetal effects of maternal nausea and vomiting and their treatment Management Cont…. INITIAL APPROACH — Generally, treatment begins with advice about diet, avoidance of triggers, and non-pharmacologic interventions, such as acupressure; oral or rectal medications are added if symptoms do not improve. Diet — Meals and snacks should be eaten slowly and in small amounts every one to two hours to avoid a full stomach. Women with nausea should eat before, or as soon as, they feel hungry to avoid an empty stomach, which can aggravate nausea. Management Cont…. frequent small carbohydrate meals, such as soda crackers or dry toast, based primarily on historical anecdotal reports. Although scientific data on the effect of dietary components on nausea are sparse, there is some evidence that protein- predominant meals/snacks produce quantifiable decreases in nausea. Management Cont…. Woman should figure out what foods they tolerate best and try to eat those foods. Dietary manipulations that help some women include eliminating coffee and spicy, odorous, high fat, acidic, and very sweet foods, and substituting snacks/meals that are protein dominant, salty, low fat, bland, and/or dry (eg, nuts, pretzels, crackers, cereal, toast) Fluids are better tolerated if cold, clear, and carbonated or sour (eg, ginger ale, lemonade, Management Cont…. Aromatic therapies involving lemon (lemonade), mint (tea), or orange have also been described as useful. Fluids should be consumed at least 30 minutes before or after solid food to minimize the effect of a full stomach. Patients whose symptoms are related to delayed gastric emptying should improve with a diet comprised of liquids and low fat solids since these foods are more readily emptied by Nonpharmacologic interventions Avoidance of triggers: The cornerstone of nonpharmacologic therapy of hyperemesis gravidarum is avoidance of environmental triggers . Examples of some triggers include: stuffy rooms, odors (eg, perfume, chemicals, food, smoke), heat, humidity, noise, and visual or physical motion (eg, flickering lights, driving). Quickly changing position and not getting enough rest, particularly after eating, may also aggravate symptoms. Nonpharmacologic interventions Cont… Cold solid foods are tolerated better than hot solid foods because they have less odor and require less preparation time (ie, shorter exposure to the trigger if the woman is preparing her own meal). Brushing teeth after a meal, spitting out saliva, and frequently washing out the mouth can be helpful. Nonpharmacologic interventions Cont… Acupuncture and acupressure-P6 acupressure wristbands Pressure or massage at the P6 acupressure point is reported in some studies to relieve motion sickness. The point is found three of the patient's fingerbreadths proximal to the proximal wrist fold, between the palmaris longus and flexor carpi radialis tendons, shown in this picture by the tip of the pen. Nonpharmacologic interventions Cont… Nonpharmacologic interventions Cont… Hypnosis — Hypnosis has been reported to be helpful in some patients. Psychotherapy can also be a useful adjunctive therapy, particularly if psychological sources of anxiety are identified and can be ameliorated. Pharmacologic treatment Ginger — Randomized trials and controlled studies suggest that powdered ginger (1 to 1.5 grams in divided doses over 24 hours) is more effective than placebo, and equivalent to vitamin B6 (pyridoxine) for treatment of nausea and vomiting of pregnancy. larger studies are needed to establish the safety and efficacy of ginger. Pharmacologic treatment Cont… Pyridoxine (vitamin B6) — Pyridoxine is a water-soluble B-complex vitamin that is a necessary coenzyme in the metabolism of lipids, carbohydrates, and amino acids. It can be used as a single agent or in conjunction with doxylamine succinate for the treatment of nausea of pregnancy. As a single agent, the initial dose of pyridoxine is 25 mg orally every six to eight hours; the maximum dose suggested for pregnant Pharmacologic treatment Cont… it is a reasonable first-line treatment for nausea and vomiting of pregnancy, either alone or in combination with doxylamine succinate. Pharmacologic treatment Cont… Antihistamines (H1 antagonists The most commonly used antihistamine is doxylamine in combination with pyridoxine. Other antihistamines that have been used independently to treat nausea and vomiting of pregnancy include meclizine , dimenhydrinate , and diphenhydramine . Pharmacologic treatment Cont… The primary mechanism of antihistamines in treatment of nausea and vomiting of pregnancy is: direct inhibition of histamine at the histamine 1 (H1) receptor. the secondary mechanism is an indirect effect on the vestibular system by decreasing stimulation of the vomiting center. In addition, these agents inhibit the muscarinic receptor, which may mediate the Pharmacologic treatment Cont… Doxylamine succinate and pyridoxine is an antihistamine that is usually taken with pyridoxine. The combination appears to improve efficacy and was the formulation for Bendectin. Bendectin was voluntarily withdrawn from the market in 1983 due to lawsuits alleging teratogenicity, although scientific evidence supports its safety. Initially, two delayed release tablets of Diclectin (a total of doxylamine 20 mg and pyridoxine 20 Pharmacologic treatment Cont… SECONDARY APPROACH Women without dehydration: First-line therapy: Antihistamines (H1 antagonists): Diphenhydramine — Diphenhydramine 25 to 50 mg can be taken orally every four to six hours, as needed. It can also be given intravenously 10 to 50 mg every four to six hours, as needed. Pharmacologic treatment Cont… Meclizine — Meclizine 25 mg can be taken orally every four to six hours, as needed. Meclizine has caused cleft palate in rats. Three large studies did not show an increased risk of malformations. Pharmacologic treatment Cont… Dimenhydrinate — When oral medications are tolerated, dimenhydrinate 25 to 50 mg can be taken orally every four to six hours, as needed. Otherwise, 50 mg dimenhydrinate is administered intravenously over 20 minutes or 50 to 100 mg is administered rectally (where available) every four to six hours, as needed; the total dose should not exceed 400 mg/day. Pharmacologic treatment Cont… Second-line therapy Dopamine antagonists During nausea and vomiting, dopamine receptors in the stomach mediate the inhibition of gastric motility and, therefore, may provide a site of action for antiemetic dopamine receptor antagonists. Dopamine, specifically at the dopamine 2 receptors, is also implicated in emetic signaling through the chemoreceptor trigger Pharmacologic treatment Cont… • The three main classes of dopamine receptor antagonists are phenothiazines ( promethazine and prochlorperazine) butyrophenones ( droperidol ), and benzamides ( metoclopramide ). Pharmacologic treatment Cont… Prochlorperazine and chlorpromazine: Prochlorperazine 5 to 10 mg orally, intravenously, or intramuscularly every six hours or 25 mg per rectum twice per day, as needed, appears to benefit some patients. Pharmacologic treatment Cont… Metoclopramide — Metoclopramide 10 mg orally, intravenously, or intramuscularly (ideally 30 minutes prior to meal and at bedtime) every six to 8 hours is commonly prescribed for nausea and vomiting related to pregnancy. In the only randomized trial evaluating this drug in women with hyperemesis, metoclopramide 10 mg was as effective as promethazine 25 mg. Maternal side effects are a concern, especially Pharmacologic treatment Cont… Disadvantages include prominent sedation and risk of dystonic reactions. Pharmacologic treatment Cont… Serotonin antagonists — Ondansetron , granisetron , and dolasetron are selective antagonists at the 5-HT3 serotonin receptor. Ondansetron — Ondansetron 4 to 8 mg can be taken orally every eight hours, as needed, or administered intravenously by bolus injection every eight hours, as needed. Headache, fatigue, constipation, and drowsiness are the most common side effects. Ondansetron can cause QT prolongation, particularly in patients with underlying heart Pharmacologic treatment Cont… Adjunctive therapy Acid reducing agents — Acid reducing medications can be used as adjunctive therapy. In women with heartburn/acid reflux and nausea/vomiting of pregnancy, an observational study found that acid-reducing pharmacotherapy (eg, antacids, H2 blockers, proton pump inhibitors) combined with anti- emetic therapy resulted in significant Pharmacologic treatment Cont… Antacids containing aluminum or calcium are safe and preferable to those containing bismuth or bicarbonate, which may have adverse fetal/neonatal effects. The greatest experience with pharmacologic acid-suppressive therapy in pregnant women has been with the H2 receptor antagonists ranitidine and cimetidine , which appear to be safe during pregnancy. Pharmacologic treatment Cont…
Women with any of the following conditions need
to be admitted for in patient management. severe vomiting weight loss Ketonuria dry mucous membranes poor skin turgor dehydration, hypotension alkalosis from hydrochloric acid loss, Pharmacologic treatment Cont… In women with persistent vomiting after hospitalization, it is important to exclude underlying diseases that can cause hyperemesis. These patients and their families often need emotional support to help deal with stress and anxiety about the maternal illness and its effect on the fetus, and the disruption to their home- and work-related activities. In some cases, psychiatric consultation can be Fluids and nutrition Many patients respond to intravenous hydration and a short period of gut rest, followed by reintroduction of oral intake and pharmacologic therapy. Fluids: 2 L intravenous Ringer’s lactate infused over three to five hours, supplemented with appropriate electrolytes and vitamins. Subsequently, the infusion rate is adjusted to maintain a urine output of at least 100 mL/hour and the solution is changed to dextrose 5% in 0.45% saline. Fluids and nutrition Cont… dextrose infusion should be delayed until after the patient has received thiamine in her initial rehydration fluid, at least it should be given equally, but not before thiamine supplementation. Vitamins and minerals: If the patient is experiencing persistent vomiting, it is important to replenish low levels of vitamins (especially thiamine), electrolytes, and minerals (ie, magnesium, calcium, and phosphorous).
each day administer a multivitamin (MVI)
Fluids and nutrition Cont… • Diet — A diet that attempts to minimize nausea and vomiting can be resumed after a short period of gut rest. We usually begin women on a diet consisting of bananas, rice, applesauce, and toast (BRAT diet) and then advance their diet as tolerated. Consistent protein intake is key in helping prevent nausea. Chlorpromazine — We have found REFRACTORY PATIENTS chlorpromazine (25 to 50 mg intravenously or intramuscularly or 10 to 25 mg orally every four to six hours) to be helpful in refractory cases. A rectal suppository may be available in some countries. Adverse effects include extrapyramidal reactions, orthostatic hypotension, anticholinergic effects, and altered cardiac Glucocorticoids Glucocorticoids have been used in women with severe and refractory hyperemesis, although the mechanism of action is not well understood. Glucocorticoid use has been associated with a slightly increased risk of oral clefts when the drug is administered before 10 weeks of gestation; therefore, ideally, use of glucocorticoids should be avoided in the first trimester. Glucocorticoids Cont… An effective dose is methylprednisolone (16 mg) intravenously every 8 hours for 48 to 72 hours. Methylprednisolone can be stopped abruptly if there is no response, and tapered over two weeks in women who experience relief of symptoms. After intravenous therapy, we can use an oral prednisone taper regimen of: 40 mg oral prednisone per day for one day, followed by 20 mg per day for three days, followed by Enteral and parenteral nutrition Women who are refractory to all pharmacologic and nonpharmacologic interventions should be supported with enteral (tube feedings) or parenteral nutrition and intravenous fluids as long as necessary. In general, enteral nutrition is begun in women who cannot maintain their weight because of vomiting and despite a trial of the interventions. Enteral nutrition via gastric or duodenal intubation is preferable to the parenteral route and may relieve the nausea and vomiting. Increased risk of complication, infusion catheter MANAGEMENT OF STABLE AND IMPROVING PATIENTS Continue the drug regimen that has been effective until the patient has been completely asymptomatic (no nausea or vomiting) for at least a week. At that time, discontinue the medications and see how she does. If nausea and vomiting recurs, we resume therapy. OUTCOME AND PROGNOSIS women with severe vomiting who require multiple hospitalizations may not have "catch up" weight gain; an adverse effect on birthweight is more likely in these women . Women who have less than 7 kg weight gain are more likely to have a preterm birth/low birth weight infant, small for gestational age neonate and 5- minute a Apgar scores less than 7. There are no good data on long-term maternal Recurrence Two population based series reported the risk of recurrent hyperemesis in a second pregnancy was 15 and 20 percent in women with previous hyperemesis, but only 0.7 percent in women with no such history. PREVENTION Ideally, all women of child-bearing age should be advised to take a daily multivitamin with folic acid beginning in the preconception period; this reduces the risk of congenital anomalies, particularly neural tube defects, and may help to decrease the frequency and severity of nausea and vomiting during pregnancy. The positive effects of multivitamins are likely due to the general optimization of nutritional PREVENTION In addition, heartburn and acid reflux have been associated with increased severity of nausea and vomiting of pregnancy, which suggests that managing these disorders prior to pregnancy might prevent or reduce the severity of symptoms. Complication Electrolyte imbalance Nutritional deficiencies Wernicke encephalopathy Pneumomediastinum Esophagial rupture Esophageal tears (Mallory-Weiss) osmotic demyelination syndrome (formerly known as central pontine myelinolysis) hepatic insufficiency, and acute tubular necrosis Reference • Up to date 21.2 • Williams obstetric 24th ed. • Creasy& Resnik’s Maternal- Fetal Medicine • D.C. Dutta’s Text book of obstetrics